Tohoku J. Exp. Med., 2018 September, 246(1)
Concomitance of Polymorphisms in Glutathione Transferase Omega Genes Is Associated with Risk of Clear Cell Renal Cell Carcinoma
TANJA M. RADIC,1,2 VESNA M. CORIC,1,2 MARIJA S. PLJESA-ERCEGOVAC,1,2 GORDANA M. BASTA-JOVANOVIC,2,3 SANJA M. RADOJEVIC-SKODRIC,2,3 DEJAN P. DRAGICEVIC,2,4 MARIJA G. MATIC,1,2 LJILJANA M. BOGDANOVIC,2,3 ZORAN M. DZAMIC,2,4 TATJANA P. SIMIC1,2 and ANA R. SAVIC-RADOJEVIC1,2
1Institute of Medical and Clinical Biochemistry, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
2Faculty of Medicine, University of Belgrade, Belgrade, Serbia
3Institute of Pathology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
4Clinic of Urology, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
Glutathione S-transferases (GSTs), a superfamily of multifunctional enzymes, play an important role in the onset and progression of renal cell carcinoma (RCC). However, novel GST omega class (GSTO), consisting of GSTO1-1 and GSTO2-2 isoenzymes, has not been studied in RCC yet. Two coding single nucleotide polymorphisms (SNPs) supposedly affect their functions: GSTO1*C419A (rs4925) causing alanine to aspartate substitution (*A140D) and GSTO2*A424G (rs156697) causing asparagine to aspartate substitution (*N142D), and have been associated with several neurodegenerative diseases and cancers. Functional relevance of yet another GSTO2 polymorphism, identified at the 5' untranslated (5'UTR) gene region (GSTO2*A183G, rs2297235), has not been clearly discerned so far. Therefore, we aimed to assess the effect of specific GSTO1 and GSTO2 gene variants, independently and in interaction with established risk factors (smoking, obesity and hypertension) on the risk for the most aggressive RCC subtype, the clear cell RCC (ccRCC). Genotyping was performed in 239 ccRCC patients and 350 matched controls, while plasma levels of 8-hydroxy-2'-deoxyguanosine (8-OHdG), a biomarker of oxidative DNA damage, were determined by ELISA. As a result, combined effect of all three variant genotypes exhibited almost 3-fold risk of RCC development. Additionally, this association was confirmed at the haplotype level [variant GSTO1*A/GSTO2*G (rs156697)/GSTO2*G (rs2297235) haplotype], suggesting a potential role of those variants in propensity to RCC. Regarding the gene-environment interactions, variant GSTO2*G (rs156697) homozygous smokers are at higher ccRCC risk. Association in terms of oxidative DNA damage was found for GSTO2 polymorphism in 5'UTR and 8-OHdG. In conclusion, the concomitance of GSTO polymorphisms may influence ccRCC risk.
Key words —— GSTO1; GSTO2; oxidative DNA damage; polymorphism; renal cell carcinoma
© 2018 Tohoku University Medical Press
Tohoku J. Exp. Med., 2018, 246, 35-44
Correspondence: Ana R. Savic-Radojevic, M.D., Ph.D., Institute of Medical and Clinical Biochemistry, Faculty of Medicine, University of Belgrade, Pasterova 2, 11000 Belgrade, Serbia.